• von Willebrand Disease 2N (Subtype Normandy), Genotyping
  • Immunoglobulins (IgG, IgA, IgM)
  • Protein Creatinine Ratio, Random, Urine
  • Lactate, CSF
  • Cytochrome P450 3A7 (CYP3A7) Genotyping
  • Complement Component CH50
  • Mycoplasma pneumoniae, Molecular
  • Kell K/k Antigen (KEL) Genotyping
  • Carnitine Palmitoyltransferase II Deficiency, Gene Mutation Analysis
  • Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA) Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
Medical Test

Additional Testing
Access to Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis is restricted.
Loading...